Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Emmanuel Colombo

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
The Oncologist|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer networkNicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, et al.
Annales De Pathologie|December 17, 2011
[Locally advanced rectal cancer management: which role for the pathologist in 2011?]Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
Histopathology|April 11, 2012
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosisFelipe C Geyer, Magali Lacroix-Triki, Pierre-Emmanuel Colombo, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Cell Death & Disease|June 9, 2025
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer modelsKévin Bigot, Cindy Patinote, Véronique Garambois, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Breast (Edinburgh, Scotland)|May 6, 2017
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)Gilles Houvenaeghel, Eric Lambaudie, Monique Cohen, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
The Oncologist|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer networkNicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, et al.
Annales De Pathologie|December 17, 2011
[Locally advanced rectal cancer management: which role for the pathologist in 2011?]Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
Histopathology|April 11, 2012
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosisFelipe C Geyer, Magali Lacroix-Triki, Pierre-Emmanuel Colombo, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Cell Death & Disease|June 9, 2025
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer modelsKévin Bigot, Cindy Patinote, Véronique Garambois, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Breast (Edinburgh, Scotland)|May 6, 2017
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)Gilles Houvenaeghel, Eric Lambaudie, Monique Cohen, et al.
Pageof 9